UPDATE : Monday, December 9, 2019
상단여백
‘Lung cancer screening was effective in numerous studies’ by Jeong Sae-im 2019-11-07 14:06
Court rejects arrest warrant for 2 Kolon execs by Jeong Sae-im 2019-11-05 13:54
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals by Jeong Sae-im 2019-11-04 15:52
Kolon allegedly knew Inovossa mislabeling before applying for approval by Jeong Sae-im 2019-11-01 15:07
Prosecutors seek to arrest 2 Kolon execs for false Invossa data by Jeong Sae-im 2019-10-31 15:34
라인
Regulator to do quality test on botulinum toxin products by Jeong Sae-im 2019-10-31 14:24
Syntekabio passes prior review for Kosdaq listing by Jeong Sae-im 2019-10-31 13:27
71 pharmaceutical CEOs gather to boost new drug development by Jeong Sae-im 2019-10-30 12:40
Prosecution seeks jail term for Samsung execs for destroying evidence by Jeong Sae-im 2019-10-29 13:10
KangStem Biotech changes strategy for atopic dermatitis drug by Jeong Sae-im 2019-10-28 15:34
라인
Bridge Biotherapeutics passes preliminary review for Kosdaq listing by Jeong Sae-im 2019-10-25 15:05
KangStem Biotech fails in phase-3 study on atopic dermatitis drug by Jeong Sae-im 2019-10-25 11:17
Value assessment on anticancer drugs hotly discussed by Jeong Sae-im 2019-10-24 13:46
PharmAbcine sets up US unit to develop anticancer drug by Jeong Sae-im 2019-10-23 15:48
‘Oral drugs as effective as inhalers for elderly with asthma’ by Jeong Sae-im 2019-10-22 15:48
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’ by Jeong Sae-im 2019-10-21 16:42
Drug firms’ Q3 earnings to be fairly good by Jeong Sae-im 2019-10-21 12:27
Medytox exported ₩3.3 billion worth of unqualified BTX by Jeong Sae-im 2019-10-18 16:02
US sales of Remicade drop due to biosimilar’s rise by Jeong Sae-im 2019-10-17 13:32
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar by Jeong Sae-im 2019-10-16 14:16
여백
여백
여백
Back to Top